Trial intelligence / Profile preview

Post-marketing reassessment of Zhuifengtougu Capsules for lumbar disc herniation

ChiCTR2000028794Phase 4Completed

Sponsor
Temporarily not sure
Start
Sep 2019
Countries
1
01

Overview

Phase 4, open-label trial of zhuifengtougu in Herniated Lumbar Disk (2 arms), sponsored by Temporarily not sure. Primary endpoint: VAS score. Started Sep 2019; status: completed.

02

Drugs

zhuifengtougu
03

Conditions

Herniated Lumbar Disk

Beyond the preview

Go deeper on ChiCTR2000028794.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000028794.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call